Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Accounts Payables (2017 - 2025)

Inspire Medical Systems' Accounts Payables history spans 9 years, with the latest figure at $36.6 million for Q4 2025.

  • For Q4 2025, Accounts Payables fell 5.49% year-over-year to $36.6 million; the TTM value through Dec 2025 reached $36.6 million, down 5.49%, while the annual FY2025 figure was $36.6 million, 5.49% down from the prior year.
  • Accounts Payables for Q4 2025 was $36.6 million at Inspire Medical Systems, down from $59.2 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $59.2 million in Q3 2025 and bottomed at $8.7 million in Q2 2021.
  • The 5-year median for Accounts Payables is $34.3 million (2024), against an average of $30.2 million.
  • The largest annual shift saw Accounts Payables soared 149.24% in 2023 before it crashed 33.48% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $11.7 million in 2021, then surged by 130.15% to $26.8 million in 2022, then skyrocketed by 44.67% to $38.8 million in 2023, then dropped by 0.39% to $38.7 million in 2024, then fell by 5.49% to $36.6 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Accounts Payables are $36.6 million (Q4 2025), $59.2 million (Q3 2025), and $53.2 million (Q2 2025).